Background Traditionally, acromegaly evaded diagnosis until in its clinically obvious later
stages when treatment is more difficult. Over the last 25 years diagnostic tests have …

Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion.
While diagnostic and therapeutic methods have advanced, little information exists on trends …

Abstract Design Valid data on acromegaly incidence, complications and mortality are
scarce. The Danish Health Care System enables nationwide studies with complete follow-up …

Background: The increased morbidity and mortality of acromegaly makes early diagnosis
and therapy critical. However, whether the type of medical professional who first diagnoses …

Abstract Purpose The 14th Acromegaly Consensus Conference was convened to consider
biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy …

Objective To undertake a multicentre epidemiological study reflecting acromegaly in Spain.
Design Voluntary reporting of data on patients with acromegaly to an online database, by …

Acromegaly is an uncommon, chronic disease, characterized by hypersecretion of a pituitary
growth hormone by somatotroph adenomas, along with increased levels of insulin-like …

Although morbility and mortality in acromegaly are higher than in the general population,
there have been very few previous epidemiological studies. This study tries to answer “why” …

Purpose Acromegaly is characterized by a broad range of manifestations. Early diagnosis is
key to treatment success, but is often delayed as symptomatology overlaps with common …

Abstract Objectives The French Acromegaly Registry records data of acromegalic patients'
since 1992 in French, Belgian (Liège), and Swiss (Lausanne) centers. We studied the …